4//SEC Filing
Sinha Vikas 4
Accession 0001104659-25-051986
CIK 0001657312other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:06 PM ET
Size
9.9 KB
Accession
0001104659-25-051986
Insider Transaction Report
Form 4
Sinha Vikas
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2025-05-20$0.50/sh+160,000$80,608→ 234,440 total - Sale
Ordinary Shares
2025-05-20$9.39/sh−160,000$1,502,928→ 74,440 total - Exercise/Conversion
Share Options (Right to Buy)
2025-05-20−160,000→ 384 totalExercise: $0.50Exp: 2032-04-27→ Ordinary Shares (160,000 underlying)
Footnotes (6)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2024.
- [F3]The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were sold in multiple transactions at per share prices ranging from $9.375 to $9.4263, inclusive (or $75.00 to $75.41 per ADS, inclusive). The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.
- [F4]Consists of 74,440 Ordinary Shares represented by 9,305 ADSs.
- [F5]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F6]The option is fully vested.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001337845
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:06 PM ET
- Size
- 9.9 KB